Partnerships

We work with academic and industrial partners on difficult electrosynthesis problems spanning reaction discovery, mechanism and batch-to-flow translation.

Problems we can help solve

We combine synthetic electrochemistry, electroanalysis, reaction development and flow processing to address defined chemical and process constraints.

Electrochemical feasibility

Determine whether a difficult oxidation or reduction can be achieved through controlled electrical input.

Reactive intermediates

Generate unstable or hazardous intermediates only when needed, then consume them within the same controlled sequence.

Mechanistic analysis

Use voltammetry, controlled-potential experiments, spectroscopy, product studies and rapid NMR, GC–MS, LC–MS or headspace analysis to define plausible pathways and operating windows.

Batch-to-flow translation

Translate reactions by controlling electrode area, current density, residence time, mass transfer, heat removal and reactive inventory.

Ways to work together

Academic collaboration

Joint mechanistic, synthetic, analytical or reactor-development projects with research groups offering complementary expertise.

Industrial collaboration

Feasibility assessment, method development, mechanistic investigation, batch-to-flow translation, collaborative doctoral research and funded projects.

Fellowship and network proposals

Co-developed proposals where the scientific question has a strong fit with the group’s established expertise and facilities.

Partnerships in practice

Published collaboration case studies

These examples show how a defined medicinal- or process-chemistry problem can move from reaction design to a published method, including translation from batch to flow where appropriate.

GSK · Process chemistry

eCarbonyls: safer alcohol oxidation for batch and flow

Together with GSK, the group investigated how electrosynthesis could support scalable process chemistry, focusing on oxidation reactions that conventionally rely on hazardous reagents or demanding conditions.

eCarbonyls converts primary and secondary alcohols into aldehydes and ketones at room temperature using a stable thioether mediator. The method was demonstrated in batch and flow, including multigram synthesis, as a safer and process-relevant alternative to classical oxidation.

Published outcome: Chemical Science, 2025.

Read the eCarbonyls publication ↗

AstraZeneca · Medicinal and process chemistry

eSpiro: three-dimensional scaffolds with flow potential

Spiroketals provide three-dimensional scaffolds that help medicinal chemists move beyond predominantly flat aromatic structures.

The batch electrosynthesis was developed in the Lam Research Group and then translated to a preliminary flow setup with AstraZeneca Chemical Development in Macclesfield. The study provided proof of concept for batch-to-flow translation while identifying practical process challenges including substrate stability, gas evolution and an in-line solvent change.

Published outcome: Green Chemistry, 2025.

Read the eSpiro publication ↗

Janssen R&D, Belgium · Discovery chemistry

Direct electrocyanation of N-heterocycles

With Discovery Chemistry at Janssen R&D in Beerse, the group developed a direct C(sp²)–H electrocyanation of aromatic N-heterocycles. The method was demonstrated in batch and flow across drug-like heterocycles and enabled direct cyanation of unprotected N–H indoles, substrates that are particularly challenging under oxidative conditions.

Published outcome: Chemistry – A European Journal, 2022.

Read the electrocyanation publication ↗

Janssen-Cilag, Spain · Discovery chemistry

Rapid three-dimensional functionalisation of N-heterocycles

With Janssen-Cilag in Toledo and the University of Castilla-La Mancha, the group combined anodic generation of aminal intermediates with Lewis-acid-promoted iminium formation and organozinc addition under flow. The two-stage method forms secondary, tertiary and quaternary carbon centres on saturated N-heterocycles and was demonstrated in the derivatisation of peptides and an active pharmaceutical ingredient.

Published outcome: Advanced Synthesis & Catalysis, 2021.

Read the C(sp³)–C(sp³) publication ↗

Research support

Selected support and collaboration

Our work has been supported through research funding, industrial collaboration and specialist equipment partnerships.

Johnson & Johnson and Janssen
AstraZeneca
GSK
IKA
EPSRC
Innovate UK
The Leverhulme Trust
European Innovation Council
Marie Skłodowska-Curie Actions
American Chemical Society

Research funding

  • Engineering and Physical Sciences Research Council
  • Innovate UK
  • The Leverhulme Trust
  • ACS Petroleum Research Fund
  • Department for Business, Energy & Industrial Strategy

European programmes

  • Horizon Europe EIC Pathfinder
  • Marie Skłodowska-Curie Postdoctoral Fellowships
  • Marie Skłodowska-Curie Doctoral Networks

Industrial collaboration and sponsorship

  • AstraZeneca
  • GSK
  • Johnson & Johnson and Janssen

Equipment and capability support

  • IKA

Discuss a collaboration

Send a brief non-confidential summary of the chemical or process constraint, the target scale, the evidence already available and any timing requirements. Do not include proprietary structures or confidential results in the first message.

Confidentiality, contracting and intellectual-property arrangements are handled through the University’s approved processes after an initial non-confidential discussion.

Start a collaboration enquiry